VERO Logo

Venus Concept Inc. (VERO) 

NASDAQ
Market Cap
$2.61M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
935 of 959
Rank in Industry
117 of 120

Largest Insider Buys in Sector

VERO Stock Price History Chart

VERO Stock Performance

About Venus Concept Inc.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional …

Insider Activity of Venus Concept Inc.

Over the last 12 months, insiders at Venus Concept Inc. have bought $0 and sold $383,356 worth of Venus Concept Inc. stock.

On average, over the past 5 years, insiders at Venus Concept Inc. have bought $6.61M and sold $732,502 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 60,000 shares for transaction amount of $13,200 was made by PORTARO ROSS (President Global Sales) on 2022‑11‑21.

List of Insider Buy and Sell Transactions, Venus Concept Inc.

2024-12-03Saledirector
42,768
0.5866%
$0.31$13,194+3.11%
2024-10-02Sale10 percent owner
94,553
1.178%
$0.53$50,160-29.41%
2024-10-01Sale10 percent owner
140,214
1.9599%
$0.60$83,455-35.43%
2024-09-30Sale10 percent owner
71,368
1.0809%
$0.64$46,025-39.43%
2024-06-11Sale10 percent owner
102,717
1.757%
$1.20$122,829-53.18%
2024-06-07Sale10 percent owner
55,382
1.1453%
$1.22$67,692-43.98%
2022-11-29Saledirector
51,431
0.0049%
$0.24$12,503-34.44%
2022-11-28Saledirector
51,428
0.0052%
$0.27$13,680-36.39%
2022-11-25Saledirector
51,428
0.0051%
$0.31$15,752-44.94%
2022-11-23Saledirector
51,428
0.0046%
$0.33$16,971-53.33%
2022-11-22Saledirector
51,428
0.0044%
$0.20$10,106-25.27%
2022-11-21PurchasePresident Global Sales
60,000
0.0062%
$0.22$13,200-16.67%
2022-11-18PurchaseOfficer
1.25M
0.1312%
$0.20$250,000-5.56%
2022-11-18Purchasedirector
250,000
0.0262%
$0.20$50,000-5.56%
2022-11-18PurchasePresident/Chief Bus. Officer
250,000
0.0262%
$0.20$50,000-5.56%
2022-09-16PurchaseChief Financial Officer
60,000
0.0059%
$0.59$35,403-65.70%
2022-09-12PurchaseVP, Global HR
12,782
0.0013%
$0.71$9,083-69.23%
2022-08-30PurchaseChief Executive Officer
37,500
0.0039%
$0.33$12,304-31.25%
2022-05-24Purchase
40,000
0.004%
$0.64$25,720-53.31%
2022-05-20PurchaseChief Executive Officer
65,000
0.007%
$0.75$48,750-57.30%

Insider Historical Profitability

<0.0001%
BARRY RICHARD SCOTT
16337856
225.1857%
$0.3620<0.0001%
EW Healthcare Partners, L.P.10 percent owner
16337856
225.1857%
$0.3620<0.0001%
Kong Garheng
6795621
93.6645%
$0.3620<0.0001%
HealthQuest Partners II, L.P.10 percent owner
6795621
93.6645%
$0.3620<0.0001%
Kliman Gilbert H
5355786
73.8191%
$0.3610

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.